RYR3 gene polymorphisms and cardiovascular disease outcomes in the context of antihypertensive treatment

Nearly one-third of adults in the U.S. have hypertension, which is associated with increased cardiovascular disease (CVD) morbidity and mortality. The goal of antihypertensive pharmacogenetic research is to enhance understanding of drug response based on the interaction of individual genetic archite...

Descripción completa

Detalles Bibliográficos
Autores principales: Lynch, Amy I, Irvin, Marguerite R, Boerwinkle, Eric, Davis, Barry R, Vaughan, Laura K, Ford, Charles E., Aissani, Brahim, Eckfeldt, John H, Arnett, Donna K, Shrestha, Sadeep
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2012
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435442/
https://www.ncbi.nlm.nih.gov/pubmed/22664477
http://dx.doi.org/10.1038/tpj.2012.22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3435442/
https://www.ncbi.nlm.nih.gov/pubmed/22664477
http://dx.doi.org/10.1038/tpj.2012.22

Ejemplares similares